Belviq's Sales Will Disappoint: Demographics Matter [View article]
Smit....
Send me your information (step up and put your real name and address) and I will file the paperwork on a harassment order citing the Internet stalking laws of Massachusetts. It will be filed in Massachusetts and you will receive your request for appearance in due time. If you say you have nothing to fear, step up and send me a PM with your information. I will file it this week.
Belviq's Sales Will Disappoint: Demographics Matter [View article]
Jaweid.....
Thank you for the comment. While I have carried out a model to longer periods of time, one of the biggest risks in any model is that any small error is compounded as the timeline goes further out.
One very strong factor I am considering is the size and scope of the market. Qsymia sales to date have given me pause. What I really want to see is how Belviq sales start out. In essence, the key to this sector is in the near and mid term. If those are ho-hum, the longer term prospects get diminished. If sales are robust, then prospects get increased.
Essentially, my model will be seeing adjustments as the initial sales come in. I see the key as the short and mid term right now.
Belviq's Sales Will Disappoint: Demographics Matter [View article]
Kcn......
The options market is a different animal. I have used opinions and traded them many times. However, percentage gains or losses still are what matters in options
Belviq's Sales Will Disappoint: Demographics Matter [View article]
Smit...
You lack any sense of courage. I have no need to use physical threats. In fact that is more likely a path you will go down given your history. You dissecting my arguments.....PLEASE.
I say scripting off label adds liability. This is backed up by scads of published information as well as the additional steps a doctor must take when they script off label. Vs. You say it does not add liability and offer nothing to back up your opinion.
Winner - me
I put numbers on the table that tie to revenue, consider fundamentals, technicals and psychology of the market Vs. You over generalize, bet on hope and market psychology.
Winner - me
I inverse with sector analysts and industry professionals in the sector Vs. You are a message board poster that falls into the trap of the musings of message board posters.
Winner - me
I discuss the issues Vs. You resort to name calling, false accusations, and stomping your feet
Belviq's Sales Will Disappoint: Demographics Matter [View article]
Smit....
I do not need to sue you. Certainly that could be an option. If you want that to happen and do not fear it feel free to send me your information in a PM.
Discovery in a case goes both ways.
You can certainly represent yourself, but would be doing so in a state that you do not likely live in, and have no license in.
I have nothing to hide.
Seeking alpha provides a modest payment. The terms of such are available for anyone to see. Are you saying that you tried to submit an article and were not aware of the terms of their payment structure? Interesting.
Belviq's Sales Will Disappoint: Demographics Matter [View article]
Smit....
My stance is simple and correct. Scripting off label adds liability to a doctor. That is not a notion. It is a fact. There are scads of papers written on the subject.
Your stance is that scripting off label does not add liability. That stance is not true at all.
Belviq's Sales Will Disappoint: Demographics Matter [View article]
You are hereby placed on notice in regard to criminal stalking as defined by Massachusetts general law chapter 265 section 43. If you continue with your abusive and annoying behavior a criminal compliant can be filed.
Belviq's Sales Will Disappoint: Demographics Matter [View article]
Maybe one day you will step up to the plate, put one numbers on the table and join the real investment community. Then again you do not seem to have the forge to do it.
I notice that you ceased the libelous type statements.....smart.
Belviq's Sales Will Disappoint: Demographics Matter [View article]
smit....
You were smart enough to phrase your post cleverly so as to have plausible deniability about what you were intending. You can employ the "who me" defense.
You know better than to go down the path of libel and slander. At least a good attorney would know better than to do that.
I suggest strongly that you do not test this issue. By even acknowledging the comment I made you have acknowledged receipt of the warning and now have no excuses should you decide to take the path of libeling or slandering me.
You only need to worry if you make statements in a libelous and slanderous manner (having received fair warning). You have now even removed the essence of plausible deniability from the equation.
Belviq's Sales Will Disappoint: Demographics Matter [View article]
steinbeck....
Thank you for the post.
Putting up with the likes of those you listed ius an unfortunate side effect of being realistic. Some day these people will come to their senses. For most it will happen too late.
I would consider 30K to be okay and showing potential to make the numbers hit (i.e. a slow start) Anything less than that will be bad.
Bear in mind, the street still carries some big projections, but that is due more to a lack of analysts updating models than anything real.
In my opinion $8 is undervalued based on the company getting 40k scripted in 3 months.
Belviq's Sales Will Disappoint: Demographics Matter [View article]
imi....
It is illeagal for Belviq to advertise anything to do with diabetes. That would be the fastated way to see hundreds of millions in fines. Look up Glaxo and the huge penalty they paid for marketing a drug of-label
Belviq's Sales Will Disappoint: Demographics Matter [View article]
joseph....
you have yet to put up numbers and now want me to provide you bwith data? That is humorous.
1 I have never stated that the obese population is not insured. In fact I have never even come close to making such a statement. That would seem to be a figment of your imagination.
2. Having insurance does not guarantee that a person with the comorbidities we are discussing will live or die. Neither does non insurance. The fact is that an uninsured person with the qualifying comorbidities can vastly improve their conditions overall by simply having a routine that includes proper diet and exercise....no insurance required. If you disagree with me, ask your doctor.
3. Belviq has a safety profile. We do not yet know if it is the safest.
4. Insurance payment will take time. It is a process.
5. None of the drugs past or present is as safe as proper diet and exercise. Proper diet and exercise could likely take care of at least 75% to 80% of the potential market.
Belviq's Sales Will Disappoint: Demographics Matter [View article]
Send me your information (step up and put your real name and address) and I will file the paperwork on a harassment order citing the Internet stalking laws of Massachusetts. It will be filed in Massachusetts and you will receive your request for appearance in due time. If you say you have nothing to fear, step up and send me a PM with your information. I will file it this week.
Belviq's Sales Will Disappoint: Demographics Matter [View article]
Let's make this real simple.
Liability is the state of being responsible for something.
When a doctor scripts off label they are responsible for more than if they script on label. What part of this do you not understand?
Because a doctor is responsible to take additional steps because he is scripting off label, he is by definition taking on added liability.
You really need to brush up on things
Belviq's Sales Will Disappoint: Demographics Matter [View article]
Thank you for the comment. While I have carried out a model to longer periods of time, one of the biggest risks in any model is that any small error is compounded as the timeline goes further out.
One very strong factor I am considering is the size and scope of the market. Qsymia sales to date have given me pause. What I really want to see is how Belviq sales start out. In essence, the key to this sector is in the near and mid term. If those are ho-hum, the longer term prospects get diminished. If sales are robust, then prospects get increased.
Essentially, my model will be seeing adjustments as the initial sales come in. I see the key as the short and mid term right now.
Belviq's Sales Will Disappoint: Demographics Matter [View article]
The options market is a different animal. I have used opinions and traded them many times. However, percentage gains or losses still are what matters in options
Belviq's Sales Will Disappoint: Demographics Matter [View article]
You lack any sense of courage. I have no need to use physical threats. In fact that is more likely a path you will go down given your history. You dissecting my arguments.....PLEASE.
I say scripting off label adds liability. This is backed up by scads of published information as well as the additional steps a doctor must take when they script off label.
Vs.
You say it does not add liability and offer nothing to back up your opinion.
Winner - me
I put numbers on the table that tie to revenue, consider fundamentals, technicals and psychology of the market
Vs.
You over generalize, bet on hope and market psychology.
Winner - me
I inverse with sector analysts and industry professionals in the sector
Vs.
You are a message board poster that falls into the trap of the musings of message board posters.
Winner - me
I discuss the issues
Vs.
You resort to name calling, false accusations, and stomping your feet
Winner - me
Belviq's Sales Will Disappoint: Demographics Matter [View article]
I did not threaten. I am the one being stalked, and having libelous statements made about me.
Belviq's Sales Will Disappoint: Demographics Matter [View article]
I do not need to sue you. Certainly that could be an option. If you want that to happen and do not fear it feel free to send me your information in a PM.
Discovery in a case goes both ways.
You can certainly represent yourself, but would be doing so in a state that you do not likely live in, and have no license in.
I have nothing to hide.
Seeking alpha provides a modest payment. The terms of such are available for anyone to see. Are you saying that you tried to submit an article and were not aware of the terms of their payment structure? Interesting.
Belviq's Sales Will Disappoint: Demographics Matter [View article]
My stance is simple and correct. Scripting off label adds liability to a doctor. That is not a notion. It is a fact. There are scads of papers written on the subject.
Your stance is that scripting off label does not add liability. That stance is not true at all.
Belviq's Sales Will Disappoint: Demographics Matter [View article]
http://bit.ly/15Exf1i
Belviq's Sales Will Disappoint: Demographics Matter [View article]
I notice that you ceased the libelous type statements.....smart.
Belviq's Sales Will Disappoint: Demographics Matter [View article]
You were smart enough to phrase your post cleverly so as to have plausible deniability about what you were intending. You can employ the "who me" defense.
You know better than to go down the path of libel and slander. At least a good attorney would know better than to do that.
I suggest strongly that you do not test this issue. By even acknowledging the comment I made you have acknowledged receipt of the warning and now have no excuses should you decide to take the path of libeling or slandering me.
You only need to worry if you make statements in a libelous and slanderous manner (having received fair warning). You have now even removed the essence of plausible deniability from the equation.
Belviq's Sales Will Disappoint: Demographics Matter [View article]
Thank you for the post.
Putting up with the likes of those you listed ius an unfortunate side effect of being realistic. Some day these people will come to their senses. For most it will happen too late.
I would consider 30K to be okay and showing potential to make the numbers hit (i.e. a slow start) Anything less than that will be bad.
Bear in mind, the street still carries some big projections, but that is due more to a lack of analysts updating models than anything real.
In my opinion $8 is undervalued based on the company getting 40k scripted in 3 months.
Belviq's Sales Will Disappoint: Demographics Matter [View article]
It is illeagal for Belviq to advertise anything to do with diabetes. That would be the fastated way to see hundreds of millions in fines. Look up Glaxo and the huge penalty they paid for marketing a drug of-label
Belviq's Sales Will Disappoint: Demographics Matter [View article]
you have yet to put up numbers and now want me to provide you bwith data? That is humorous.
1 I have never stated that the obese population is not insured. In fact I have never even come close to making such a statement. That would seem to be a figment of your imagination.
2. Having insurance does not guarantee that a person with the comorbidities we are discussing will live or die. Neither does non insurance. The fact is that an uninsured person with the qualifying comorbidities can vastly improve their conditions overall by simply having a routine that includes proper diet and exercise....no insurance required. If you disagree with me, ask your doctor.
3. Belviq has a safety profile. We do not yet know if it is the safest.
4. Insurance payment will take time. It is a process.
5. None of the drugs past or present is as safe as proper diet and exercise. Proper diet and exercise could likely take care of at least 75% to 80% of the potential market.
Belviq's Sales Will Disappoint: Demographics Matter [View article]
I have outclassed you in every sense of the word. You are simply to blind o see it.